Magsari, Rowena .

HRN: 21-95-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/13/2022
10/16/2022
PO
5ml
BID
Ascariasis; Trichiuriasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: